[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![$oncs Graphic](https://lunarcrush.com/gi/w:26/t:$oncs.png) $oncs

$ONCS sees a surge in engagements, fueled by positive community sentiment. Analysts predict durable growth for $ONCS with upcoming data readouts.

### About $oncs
A cryptocurrency.  

### Engagements: X [#](/topic/$oncs/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$oncs/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$oncs/time-series/interactions.tsv)  
**Current Value**: X  
**Daily Average**: XXX  
**1 Week**: XXX -XX%  
**1 Month**: XXX -XX%  
**1-Year High**: XXXXX on 2025-08-11  
**1-Year Low**: X on 2025-05-04  

| Social Network | X |
| -------------- | - |
| Engagements    | X |
  

  
  
### Mentions: X [#](/topic/$oncs/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$oncs/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$oncs/time-series/posts_active.tsv)  
**Current Value**: X  
**Daily Average**: X  
**1-Year High**: XX on 2025-08-12  
**1-Year Low**: X on 2025-05-01  

| Social Network | X |
| -------------- | - |
| Mentions       | X |
  

  
  
### Creators: X [#](/topic/$oncs/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$oncs/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$oncs/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning $oncs in the last XX hours which is no change from in the previous XX hours
**Daily Average**: X  
**1-Year High**: X on 2025-07-18  
**1-Year Low**: X on 2025-05-01  

**Top assets mentioned**
In the posts about $oncs in the last XX hours

[One Cash (ONC)](/topic/$onc)
[Alnylam Pharmaceuticals, Inc. (ALNY)](/topic/alnylam-pharmaceuticals-inc)

**Top topics mentioned**
In the posts about $oncs in the last XX hours

[$onc](/topic/$onc), [coins stablecoin](/topic/coins-stablecoin), [$barcl](/topic/$barcl), [$cvac](/topic/$cvac), [$bntx](/topic/$bntx), [stocks healthcare](/topic/stocks-healthcare), [alnylam pharmaceuticals inc](/topic/alnylam-pharmaceuticals-inc)

### Top Social Posts [#](/topic/$oncs/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"$ONCS $CVAC $BNTX $ALNY $EBS $ADPT $ARCT $TBIO $VXRT $ATRA $VBIV $ALT $DVAX $IBIO $HTBX $TNXP $PDSB $TFX $GOVX $IGC $XNCR $FPRX $INCY $AGIO $GBT $HALO $ALKS $KPTI $CARA $ZGNX $TMO $EW $DXCM $IDXX $NVTA $HZNP $BMRN $VRTX $ABT $MDT $BSX $GME $AMC $BTC $jd $baba $anf $nvda $mstr"  
[X Link](https://x.com/edward_petez/status/1976719002023157923) [@edward_petez](/creator/x/edward_petez) 2025-10-10T18:38Z 1132 followers, XXX engagements


"Barclays🏁 $ONC Overweight-$385 and said BeOne (ONC) is a commercial oncology company developing therapies across hematologic and solid tumors. $ONC's broad oncology pipeline positions it for durable growth. Barclay additionally said: We initiate coverage of BeOne (ONC) with an Overweight rating and $XXX PT ahead of two value-inflecting pivotal data readouts; 1) Data for BTK inhibitor in first line mantle cell lymphoma in 2H25; and 2) Data in first line gastroesophageal cancer for PD1 inhibitor + anti-HER2 combination in 4Q25"  
[X Link](https://x.com/Quantumup1/status/1968652175699071081) [@Quantumup1](/creator/x/Quantumup1) 2025-09-18T12:23Z 3845 followers, 1382 engagements